These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20811714)

  • 21. Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells.
    Lee SJ; Park HJ; Kim YH; Kim BY; Jin HS; Kim HJ; Han JH; Yim H; Jeong SY
    Int J Mol Med; 2012 Aug; 30(2):443-50. PubMed ID: 22664653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.
    Zietsch J; Ziegenhagen N; Heppner FL; Reuss D; von Deimling A; Holtkamp N
    PLoS One; 2010 Jul; 5(7):e11858. PubMed ID: 20686603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
    Ki DH; He S; Rodig S; Look AT
    Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-₃ receptor modulates intraocular pressure: implications for glaucoma.
    Bucolo C; Leggio GM; Maltese A; Castorina A; D'Agata V; Drago F
    Biochem Pharmacol; 2012 Mar; 83(5):680-6. PubMed ID: 22178719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains.
    Castorina A; Leggio GM; Giunta S; Magro G; Scapagnini G; Drago F; D'Agata V
    Neurochem Res; 2011 Mar; 36(3):426-34. PubMed ID: 21170735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
    Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
    PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
    Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
    Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis.
    Weng Y; Chen Y; Chen J; Liu Y; Bao T
    Med Oncol; 2013 Jun; 30(2):531. PubMed ID: 23483452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft.
    Bhola P; Banerjee S; Mukherjee J; Balasubramanium A; Arun V; Karim Z; Burrell K; Croul S; Gutmann DH; Guha A
    Int J Cancer; 2010 Jan; 126(2):563-71. PubMed ID: 19634141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ejaculation induced by i.c.v. injection of the preferential dopamine D(3) receptor agonist 7-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats.
    Clément P; Bernabé J; Denys P; Alexandre L; Giuliano F
    Neuroscience; 2007 Mar; 145(2):605-10. PubMed ID: 17258866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.
    Wojtkowiak JW; Fouad F; LaLonde DT; Kleinman MD; Gibbs RA; Reiners JJ; Borch RF; Mattingly RR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):1-11. PubMed ID: 18367665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression.
    Woodfield SE; Zhang L; Scorsone KA; Liu Y; Zage PE
    BMC Cancer; 2016 Mar; 16():172. PubMed ID: 26925841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist.
    Chu E; Chu TC; Potter DE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):710-6. PubMed ID: 10869368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The possible involvement of dopamine D3 receptors in the regulation of gastric emptying in rats.
    Yoshikawa T; Yoshida N
    Life Sci; 2010 Nov; 87(19-22):638-42. PubMed ID: 20888837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
    Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
    Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.